4
Changes in Ownership
Kalaris Therapeutics, Inc. Filed Acc 0000950170-24-007404
Chief Accounting Officer sold 901 shares at $0.67 ($604)
From the SEC's structured data for this filing
Trades in this filing
Hagen Brett R · Chief Accounting Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-01-23 | Sale : show line 1 in the form | −901 | $0.67 | $604 | 96,289 | D |
| Open-market sales · 901 sh · avg $0.67 · $604 | ||||||
Loading xslF345X05/ownership.xml…